Connect with us

Hi, what are you looking for?

Investing

Altech – Results of Share Purchase Plan

Altech Batteries Limited (Altech/the Company) (ASX: ATC) provides the following update regarding its Share Purchase Plan (SPP) as announced on 17 April 2024.

Highlights

Share Purchase Plan (SPP) closed 15 May 2024Proceeds received of $3,721,000Shares and options will be issued 22 May 2024Quotation of shares on ASX 22 May 2024

The Company received applications from eligible shareholders amounting to proceeds received of $3,721,000. This represents 57,246,037 shares at $0.065 per share and 28,622,799 free-attaching options with an exercise price of $0.08 per share and expiring 30 April 2026.

The shares and options will be issued and allotted on 21 May 2024 and application for quotation of shares on the ASX will be made on 21 May 2024.

Altech’s CEO and MD Iggy Tan stated“On behalf of the Board of Directors, I wish to thank all eligible shareholders that participated in the SPP and for the support extended to Altech as it moves forward with both its CERENERGY® battery project as well as Silumina AnodesTM battery materials project. The SPP was very well received and supported. I am also cognisant of the market’s expectation in relation to the fabrication of the two 60KWh CERENERGY® battery prototypes as well as the commissioning of the Silumina AnodesTM pilot plant, and funds received from the SPP will be applied towards this. With the positive Definitive Feasibility Study and excellent economics for the 120MWh CERENERGY® battery project having been recently released in March 2024, Altech is also focused on securing offtake as well as finance to commence plant construction”.

Click here for the full ASX Release

This post appeared first on investingnews.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    There is no trial in recent history, or possibly all of American history, that can rival the one underway in Lower Manhattan. For the...

    Stock

    Meta Platforms Inc. (META), the social media giant formerly known as Facebook, has been in tight consolidation at the top of its range for...

    Stock

    Novo Nordisk (NVO) reported Q1 earnings on May 2. Even though it was a positive report, sales of its weight-loss drug Wegovy came in...

    Investing

    Output from the top uranium-producing countries rose steadily for a decade, peaking at 63,207 metric tons (MT) in 2016. However, global uranium production has...

    Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Dealwithbiz.com